Since HIV’s discovery in the 1980s, scientists have come a long way in understanding the different steps required for its assembly and maturation. Researchers knew, for instance, that HIV wraps its ...

HIV myths cause fear and stigma. Get the facts on transmission, prevention, and treatment to protect yourself and others.

Medically reviewed by Soma Mandal, MD HIV-2 is similar to HIV-1 in that they are both: Types of human immunodeficiency virus ...

A new antiretroviral target has been identified that suppresses HIV-1 replication and selectively kills HIV-1-infected cells. HIV-1 is the most common type of HIV. When HIV-1 leaves infected cells, ...

This can be due to genetic influences and/or the way the immune system reacts and adapts to the early stage of HIV infection. There is variety amongst elite controllers in the extent to which viral ...

A new study led by Western researchers is the first to identify a factor that could influence how fast the pocket where human immunodeficiency virus (HIV) hides dormant inside of cells shrinks when ...

This image shows the replication cycle of HIV/SIV. The virus replicates in the body's own CD4+ T helper cells. In doing so, it introduces its own genetic information into the DNA of the host cell.

A research group led by Professor Wei Li from the Department of Pharmacognosy, Faculty of Pharmaceutical Sciences, Toho ...

ABX464 is the company's first antiviral drug, and inhibits HIV replication through a novel mechanism, the modulation of RNA formation. It says pre-clinical studis suggest this approach could avoid ...

Feb. 18, 2025 — Viruses, like those that cause COVID-19 or HIV, are formidable opponents once they invade our bodies. Antiviral treatments strive to block a virus or halt its replication.

Efavirenz, an HIV drug, shows potential for treating chikungunya virus, inhibiting replication and reducing viral load ...